Estimates suggest that around 300 million people worldwide have asthma, among whom over 50% of adults and at least 80% of children with asthma are triggered by allergy-related factors. Probiotics can regulate the gut microbiota, maintain microbial balance, and participate in immune regulation. GenMont Biotech Incorporation has over a hundred patents, making it a leading manufacturer of probiotics in the Asia-Pacific region. Currently, GenMont’s GM-080 strain, GM-090 strain, and GMNL-133 strain have all obtained patents related to anti-allergic effects. These strains can be used to develop related health products or be applied in solid beverages, fermented milk, and other food products. (Source: xinyingyang)
Sign Up to Receive China Updates Weekly Newsletter for FREE, HERE
Visit HPA-China’s Information Hub, HERE